Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Bone mineral density in pre-and post-menopausal women with affective disorder treated with long-term L-thyroxine augmentation.

Gyulai L, Bauer M, Garcia-Espana F, Hierholzer J, Baumgartner A, Berghöfer A, Whybrow PC.

J Affect Disord. 2001 Oct;66(2-3):185-91.

PMID:
11578671
2.

Bone mineral density during maintenance treatment with supraphysiological doses of levothyroxine in affective disorders: a longitudinal study.

Bauer M, Fairbanks L, Berghöfer A, Hierholzer J, Bschor T, Baethge C, Rasgon N, Sasse J, Whybrow PC.

J Affect Disord. 2004 Dec;83(2-3):183-90.

PMID:
15555712
3.

Effect of TSH-suppressive doses of levothyroxine on bone mineral density in Thai women.

Ongphiphadhanakul B, Puavilai G, Rajatanavin R.

J Med Assoc Thai. 1996 Sep;79(9):563-7.

PMID:
8996984
4.

Prospective study of bone loss in pre- and post-menopausal women on L-thyroxine therapy for non-toxic goitre.

De Rosa G, Testa A, Giacomini D, Carrozza C, Astazi P, Caradonna P.

Clin Endocrinol (Oxf). 1997 Nov;47(5):529-35.

PMID:
9425392
5.

Bone mineral density in thyroxine treated females with or without a previous history of thyrotoxicosis.

Franklyn J, Betteridge J, Holder R, Daykin J, Lilley J, Sheppard M.

Clin Endocrinol (Oxf). 1994 Oct;41(4):425-32.

PMID:
7955453
6.

Thyroxine suppressive therapy decreases bone mineral density in post-menopausal women.

Kung AW, Lorentz T, Tam SC.

Clin Endocrinol (Oxf). 1993 Nov;39(5):535-40.

PMID:
8252741
7.

Bone mineral density and metabolism in premenopausal women taking L-thyroxine replacement therapy.

Garton M, Reid I, Loveridge N, Robins S, Murchison L, Beckett G, Reid D.

Clin Endocrinol (Oxf). 1994 Dec;41(6):747-55.

PMID:
7889610
8.

Effect of replacement doses of thyroxine on bone mineral density.

Hanna FW, Pettit RJ, Ammari F, Evans WD, Sandeman D, Lazarus JH.

Clin Endocrinol (Oxf). 1998 Feb;48(2):229-34.

PMID:
9579237
9.

Changes of bone mineral density in pre-menopausal women with differentiated thyroid cancer receiving L-thyroxine suppressive therapy.

Mazokopakis EE, Starakis IK, Papadomanolaki MG, Batistakis AG, Papadakis JA.

Curr Med Res Opin. 2006 Jul;22(7):1369-73.

PMID:
16834835
10.

Association between bone mineral densities and serum lipid profiles of pre- and post-menopausal rural women in South Korea.

Cui LH, Shin MH, Chung EK, Lee YH, Kweon SS, Park KS, Choi JS.

Osteoporos Int. 2005 Dec;16(12):1975-81. Epub 2005 Sep 16.

PMID:
16167087
11.

[Bone mineral density in patients on long-term therapy with levothyroxine].

Korsić M, Cvijetić S, Dekanić-Ozegović D, Bolanća S, Kozić B.

Lijec Vjesn. 1998 May;120(5):103-5. Croatian.

PMID:
9748785
12.
13.
14.

Bone loss in premenopausal women on long-term suppressive therapy with thyroid hormone.

Sijanovic S, Karner I.

Medscape Womens Health. 2001 Oct;6(5):3.

15.

A slightly suppressive dose of L-thyroxine does not affect bone turnover and bone mineral density in pre- and postmenopausal women with nontoxic goitre.

De Rosa G, Testa A, Maussier ML, Callà C, Astazi P, Albanese C.

Horm Metab Res. 1995 Nov;27(11):503-7.

PMID:
8770627
16.

Does subclinical hypercortisolism adversely affect the bone mineral density of patients with adrenal incidentalomas?

Hadjidakis D, Tsagarakis S, Roboti C, Sfakianakis M, Iconomidou V, Raptis SA, Thalassinos N.

Clin Endocrinol (Oxf). 2003 Jan;58(1):72-7.

PMID:
12519415
17.

Skeletal integrity in premenopausal and postmenopausal women receiving long-term L-thyroxine therapy.

Greenspan SL, Greenspan FS, Resnick NM, Block JE, Friedlander AL, Genant HK.

Am J Med. 1991 Jul;91(1):5-14.

PMID:
1858829
18.

L-thyroxin treatment and post-menopausal osteoporosis: relevance of the risk profile present in clinical history.

La Vignera S, Vicari E, Tumino S, Ciotta L, Condorelli R, Vicari LO, Calogero AE.

Minerva Ginecol. 2008 Dec;60(6):475-84.

PMID:
18981975
19.

Bone mineral density in patients with endogenous subclinical hyperthyroidism: is this thyroid status a risk factor for osteoporosis?

Földes J, Tarján G, Szathmari M, Varga F, Krasznai I, Horvath C.

Clin Endocrinol (Oxf). 1993 Nov;39(5):521-7.

PMID:
8252739
20.

Changes in bone mineral density with age, menopausal status and body mass index in Turkish women.

Ertungealp E, Seyisoglu H, Erel CT, Senturk LM, Gezer A.

Climacteric. 1999 Mar;2(1):45-51.

PMID:
11910678

Supplemental Content

Support Center